Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

(2004): Scheinfeld N, J Drugs Dermatol 3(3), 273 (passim)
Folliculitis
(2007): Gilaberte Y+, Br J Dermatol 156(2), 368 (perforating)
(2003): Devos SA+, Dermatology 206(4), 388
Granuloma annulare
(2003): Devos SA+, Dermatology 206(4), 388
Herpes simplex
(2001): Voigtländer C+, Arch Dermatol 137, 1571
Herpes zoster
(2004): Kinder A+, Postgrad Med J 80(939), 26
(2002): Baumgart DC+, Ann Rheum Dis 61(7), 661
Impetigo
(2007): Wegscheider BJ+, Eye 21(4), 547
Keratoacanthoma
(2004): Esser AC+, JAmAcadDermatol50(5 Suppl), S75
Lichenoid eruption
(2003): Devos SA+, Dermatology 206(4), 388
Lupus erythematosus
(2006): Bratcher JM+, Expert Opin Drug Saf 5(1), 9 (passim)
(2006): Chadha T+, Arthritis Rheum 55(1), 163
(2006): Pallotta P+, Rheumatology (Oxford) 45(1), 116
(2006): Perez-Garcia C+, Rheumatology (Oxford) 45(1), 114
(2006): Schneider SW+, Arch Dermatol 142(1), 115
(2005): Benucci M+, J Clin Rheumatol 11(1), 47
(2005): High WA+, JAmAcadDermatol52(4), E5
(2005): Richez C+, J Rheumatol 32(4), 760
(2005): Vabre-Latre CM+, Ann Dermatol Venereol 132(4), 349
(2004): Elkayam O+, Clin Exp Rheumatol 22(4), 502
(2004): Novak S+, Clin Exp Rheumatol 22(2), 268
(2004): Stratigos AJ+, Clin Exp Dermatol 29(2), 150
(2003): Debandt M+, Clin Rheumatol 22(1), 56
(2003): Jarrett SJ+, J Rheumatol 30(10), 2287 (8 cases)
(2003): Klapman JB+, Inflamm Bowel Dis 9(3), 176
(2003): Mikuls TR+, Drug Saf 26(1), 23
(2002): Ali Y+, AnnInternMed137(7), 625
(2000): Charles PJ+, Arthritis Rheum 43(11), 2383
Lupus syndrome
(2006): Pallotta P+, Rheumatology (Oxford) 45(1), 116
(2005): Atzeni F+, Aliment Pharmacol Ther 22(5), 453 (1 case)
(2004): Colombel JF+, Gastroenterology 126(1), 19 (3 cases)
(2003): Christopher-Stine L+, J Rheumatol 30(12), 2725
(2003): Sarzi-Puttini P+, Dig Liver Dis 35(11), 814
Lymphoma
(2006): Bratcher JM+, Expert Opin Drug Saf 5(1), 9 (passim)
(2005): Doty JD+, Chest 127(3), 1064
(2002): Brown SL+, Arthritis Rheum 46(12), 3151 (8 cases)
(2001): Aithal GP+, Aliment Pharmacol Ther 15(8), 1101
(1992): Greenstein AJ+, Cancer 69, 1119
Molluscum contagiosum (eyelids)
(2002): Cursiefen C+, Am J Ophthalmol 134(2), 270
Necrotizing fasciitis
(2002): Chan AT+, Postgrad Med J 78(915), 47
Nevi
(2006): Bovenschen HJ+, Br J Dermatol 154(5), 880 (Eruptive)
Palmar–plantar pustulosis
(2007): Roux CH+, J Rheumatol 34(2), 434
(2005): Michaelsson G+, Br J Dermatol 153(6), 1243
Peripheral edema
(2003): Gottlieb AB, JAmAcadDermatol49(2), S112
Pernio
(2003): Devos SA+, Dermatology 206(4), 388
Photosensitivity
(2002): Smith JG, Mobile, AL (2 cases) (from Internet)
(observation)
Pruritus (5%)
(2004): Scheinfeld N, J Drugs Dermatol 3(3), 273 (passim)
(2003): Gottlieb AB, JAmAcadDermatol49(2), S112
(2001): Finkelstein RP, Stratford, NJ (from Internet) (observation)
INFLIXIMAB 293
(1999): Lichenstein GR+, Biologics in Clinical Practice Symposium,
Orlando, FL, May 19
Psoriasis
(2007): Cavailhes A+, Ann Dermatol Venereol 134(4 Pt 1), 363
(2007): Cohen JD+, J Rheumatol 34(2), 380
(2007): Roux CH+, J Rheumatol 34(2), 434 (pustular) (2 cases)
(2007): Ubriani R+, Arch Dermatol 143(2), 270
(2007): Wegscheider BJ+, Eye 21(4), 547 (pustular)
(2006): Adams DR+, JDrugsDermatol5(2), 178
(2006): Gonzalez-Lopez MA+, Med Clin (Barc) 127(8), 316
(2005): Grinblat B+, Arthritis Rheum 52(4), 1333
(2005): Michaelsson G+, Br J Dermatol 153(6), 1243 (pustular)
(2005): Peramiquel L+, Clin Exp Dermatol 30(6), 713 (flexural)
(2005): Sfikakis PP+, Arthritis Rheum 52(8), 2513
(2004): Thurber M+, JDrugsDermatol3(4), 439 (pustular)
(2004): Verea MM+, Ann Pharmacother 38(1), 54
(2002): Smith SZ, Louisville, KY (from Internet) (observation)
(2001): Finkelstein RP, Stratford, NJ (from Internet) (observation)
Pustules
(2005): Starmans-Kool MJ+, Rheumatol Int 25(7), 550 (2 cases)
(2002): Chan AT+, Postgrad Med J 78(915), 47
(2001): Finkelstein RP, Stratford, NJ (from Internet) (observation)
Rash (sic) (6%)
(2006): Krathen RA+, JDrugsDermatol5(3), 251
(2004): Scheinfeld N, J Drugs Dermatol 3(3), 273 (passim)
(2003): Gottlieb AB, JAmAcadDermatol49(2), S112
(2002): Ljung T+, Scand J Gastroenterol 37(9), 1108
(2001): Serrano MS+, Ann Pharmacother 35(7), 823
(2000): Hyams JS+, JPediatr137(2), 192
(1999): Baert S+, Int J Colorectal Dis 14, 47
(1999): Lichenstein GR+, Biologics in Clinical Practice Symposium
Orlando, FL, May 19
Red man syndrome
(2003): Lobel EZ+, J Clin Gastroenterol 36(2), 186
Sarcoidosis
(2006): O’Shea FD+, Arthritis Rheum 55(6), 978
Scleredema
(2005): Ranganathan P, J Clin Rheumatol 11(6), 319
Squamous cell carcinoma
(2004): Esser AC+, JAmAcadDermatol50(5 Suppl), S75
Stevens–Johnson syndrome
(2002): Kiely PD+, Rheumatology (Oxford) 41(6), 631
Toxic epidermal necrolysis
(2007): Meiss F+, J Eur Acad Dermatol Venereol 21(5), 717
Ulcerations (foot)
(2002): Conaghan P+, Skin & Allergy News June, 40
Urticaria
(2004): Scheinfeld N, J Drugs Dermatol 3(3), 273 (passim)
(2003): Gottlieb AB, JAmAcadDermatol49(2), S112
(2001): Schaible TF, Presse Med 30(12), 610 (17%)
(1999): Lichenstein GR+, Biologics in Clinical Practice Symposium,
Orlando, FL, May 19
(1997): Van Deventer SJH, Clin Nutr 16, 271
Vasculitis
(2006): Saint Marcoux B+, Joint Bone Spine 73(6), 710
(2005): Srivastava MD+, Scand J Immunol 61(4), 329
(2004): Mohan N+, J Rheumatol 31(10), 1955 (15 cases)
(2003): Devos SA+, Dermatology 206(4), 388
(2003): Jarrett SJ+, J Rheumatol 30(10), 2287 (8 cases)
(2003): McIlwain L+, J Clin Gastroenterol 36(5), 411
Vitiligo
(2005): Ramirez-Hernandez M+, Dermatology 210(1), 79
Mucosal
Oral candidiasis
(2005): Doty JD+, Chest 127(3), 1064
Oral mucositis
(2002): Kugathasan S+, Am J Gastroenterol 97(6), 1408
Ulcerative stomatitis